With the deconsolidation of Covestro, this business will be reported as a discontinued operation in Bayer’s financial reporting for the third quarter of 2017.
For continuing operations, please find here adjusted Group figures for 2016 and Q1-Q2 2017 to exclude Covestro’s contributions.
In addition, all assets and liabilities allocated to Covestro will not feature in Bayer’s statement of financial position as of September 30. The remaining Covestro interest will be carried at the current market value, and, from October 1, 2017, will be accounted for using the equity method.
Restated key figures for 2016 and 2017Download (XLSX, 170 KB)